SCHEMBL5773537

SCHEMBL5773537

COP(=O)(Cc1ccc(NC(=O)CCc2cnoc2-c2ccc(Cl)cc2)cc1)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.43
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
LMNA P02545 4/20 0.43
GLA P06280 1/20 0.43
MAPK1 P28482 1/20 0.43
TP53 P04637 3/20 0.40
CHRM1 P11229 1/20 0.40
HTR2A P28223 1/20 0.40
MCHR1 Q99705 1/20 0.40
HDAC1 Q13547 2/20 0.39
HDAC2 Q92769 1/20 0.39
YES1 P07947 2/20 0.38
KDR P35968 2/20 0.38
JAK3 P52333 2/20 0.38
KDM4E B2RXH2 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
HDAC6 Q9UBN7 1/20 0.37
POLB P06746 3/20 0.37
RXFP1 Q9HBX9 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5775980 0.92 MEN1 (0.37) MAPTMEN1KMT2ALMNAGLA
SCHEMBL5775518 0.91 MAPT (0.43) MAPTMEN1KMT2ALMNAGLA
SCHEMBL5777014 0.91 MEN1 (0.46) MAPTMEN1KMT2ALMNAGLA
SCHEMBL5770235 0.91 MCHR1 (0.40) MAPTMEN1KMT2AMAPK1TP53
SCHEMBL5773274 0.91 KMT2A (0.46) MAPTMEN1KMT2AMAPK1TP53
SCHEMBL5770775 0.90 MAPT (0.41) MAPTMEN1KMT2ALMNAMAPK1
SCHEMBL5773492 0.88 MALT1 (0.37) MAPTMEN1KMT2ALMNAGLA
SCHEMBL5772907 0.88 TP53 (0.49) MAPTLMNATP53HTR2AMCHR1
SCHEMBL5774284 0.88 MAPT (0.37) MAPTMEN1KMT2ALMNAGLA
SCHEMBL5774259 0.87 ALDH1A1 (0.42) MAPTMEN1KMT2ALMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR MAPT 4701/4885MEN1 2811/4885KMT2A 3907/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 MAPT 4763/4885MEN1 2072/4885KMT2A 2906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.